Skip to main content

Table 3 Exposure to all types- and major-pDDIs stratified with respect to patients’ characteristics

From: Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?

Patient’s characteristicsAll types of interactionsOnly major interactions
Patients: n (%)Patients: n (%)
Gender
 Male162 (51.4)121 (52.2)
 Female153 (48.6)111 (47.8)
Age (years)
 ≤3019 (6)13 (5.6)
 31–60154 (48.9)116 (50)
 >60142 (45.1)103 (44.4)
Drugs prescribed per patient
 ≤57 (2.2)1 (0.4)
 6–10103 (32.7)60 (25.9)
 >10205 (65.1)171 (73.7)
Hospital stay (days)
 ≤247 (14.9)28 (12.1)
 3–497 (30.8)71 (30.6)
 >4171 (54.3)133 (57.3)
Comorbidities
 Hypertension173 (54.9)128 (55.2)
 Diabetes mellitus102 (32.4)77 (33.2)
 Stroke98 (31.1)75 (32.3)
 Chronic obstructive pulmonary disease25 (7.9)13 (5.6)
 Ischemic heart disease30 (9.5)25 (10.8)
 Urinary tract infection25 (7.9)21 (9.1)
 Tuberculosis22 (7)21 (9.1)
 Hepatitis16 (5.1)11 (4.7)
 Chronic kidney disease16 (5.1)9 (3.9)
 Asthma14 (4.4)10 (4.3)